YOUNG JAMES EMMETT (Chief Financial Officer) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/21/2025ACC: 0001826667-25-000063
Officer· Chief Financial Officer
Since Jan 2025
+13.18K
Net shares
Net buyer
$68.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
13.18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.18K
Price / share
$5.18
Trade value
$68.25K
% of position
36.1%
5/19/2025
36.49K→49.66K
Total
Net shares
+13.18K
Net value
$68.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2025 | A · Award | +13.18K | $5.18 | $68.25K | 36.1% | 36.49K | 49.66K |
| Total | +13.18K | $68.25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned30K
Total
30K indirect30K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 30K | Indirect |
| Total | 30K | 30K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported